Ejects of Serum Albumin and Liver Cytosol on CYP2C9- and CYP3A4-mediated Drug Metabolism

Drug Metabolism and Pharmacokinetics

Volumn 17, Issue 6, 2002, Pages 522-531

  Baba, Takahiko ^a   Touchi, Akira ^a   Yamaguchi, Yoshitaka ^a   Ito, Kiyomi ^b   Yamazoe, Yasushi ^c   Ohno, Yasuo ^d   Sugiyama, Yuichi ^e  

^a SHIONOGI AND CO LTD   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

CYP2C9; CYP3A4; cytosol; HSA; human; protein facilitated

Indexed keywords

EID: 85002594071     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.17.522     Document Type: Article

References (30)

1. Lipinski, C. A., Lombardodominy, B.W. and Feeney, P. J.: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 46: 3-26 (2001).
2. Lipinski, C. A.: Drug-like properties and the cause of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods., 44: 235-249 (2000).
3. Gillette, J. R. and Pang, K. S.: Theoretic aspects of pharmacokinetic drug interactions. Clin. Pharmacol. Ther., 22: 623-639 (1977).
4. Iwatsubo, T., Hirota, N., Ooie, T., Suzuki, H., Shimada, N., Chiba, K., Ishizaki, T., Green, C. E., Tyson, C. A. and Sugiyama, Y.: Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacol. Ther., 73: 147-171 (1997).
5. Ito, K., Iwatsubo, T., Kanamitsu, S., Nakajima, Y. and Sugiyama, Y.: Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport. Annu. Rev. Pharmacol. Toxicol., 38: 461-499 (1998).
6. Barnhart, J. L., Witt, B. L., Hardison, W. G. and RBerk, R. N.: Uptake of iopanic acid by isolated rat hepatocytes in primary culture. Am. J. Physiol., 244: G630-G636 (1983).
7. Forker, E. L. and Luxon, B. A.: Albumin helps mediate removal of taurocholate by rat liver. J. Clin. Invest., 67: 1517-1522 (1981).
8. Inoue, M., Hirata, E., Morino, Y., Nagase, S., Chowdhury, J. R., Chowdhury, N. R. and Arias, I. M.: The role of albumin in the hepatic transport of bililubin: Studies in mutanat analbuminemic rats. J. Biochem. (Tokyo), 97: 737-743 (1985).
9. Inoue, M., Okajima, K., Nagase, S. and Morino, Y.: Plasma clearance of BSP and its interaction with hepatic binding protein in normal and analbuminemic rats: Is plasma albumin essential for vectorial transport of organic anions in the liver? Proc. Natl. Acad. Sci., USA, 80: 7654-7658 (1983).
10. Tsao, S. C., Sugiyama, Y., Shinmura, K., Sawada, Y., Nagase, S., Iga, T. and Hanano, M.: Protein-mediated hepatic uptake of rose-bengal in analbuminemic mutant rats (NAR): Albumin is not indispensable to the proteinmediated transport of rose-bengal. Drug Metab. Dispos., 16: 482-489 (1988).
11. Weisiger, R. A., Gollan, J. and Ockner, R.: Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances. Science, 211: 1048-1051 (1981).
12. Forker, E. L., Luxon, B. A. and Sharma, V. S.: Hepatic transport and binding of rose bengal in the presence of albumin and gamma globulin. Am. J. Physiol., 248: G702-G708 (1985).
13. Forker, E. L. and Luxon, B. A.: Eŝects of unstirred Disse fluid, nonequilibrium binding, and surface-mediated dissociation on hepatic removal of albumin-bound organic anions. Am. J. Physiol., 248: G709-G717 (1985).
14. Ichikawa, M., Tsao, S. C., Lin, T.-H., Miyauchi, S., Sawada, Y., Iga, T., Hanano, M. and Sugiyama, Y.: Albumin-mediated transport phenomenon observed for ligands with high membrane permeability. Eŝect of the unstirred water layer in the Disse‚s space of rat liver. J. Hepatology, 16: 38-49 (1992).
15. Tsao, S. C., Sugiyama, Y., Sawada, Y., Iga, T. and Hanano, M.: Kinetic analysis of albumin-mediated uptake of warfarin by perfused rat liver. J. Pharmacokinet. Biopharm., 16: 165-181 (1988).
16. Mizuma, T., Horie, T., Hayashi, M. and Awazu, S.: Characterization of the interaction of albumin with isolated rat liver cells to reveal the mechanism of albuminmediated hepatic transport. J. Pharmacobio-dyn., 9: 244-248 (1986).
17. Ludden, L. K., Ludden, T. M., Collins, J. M., Pentikins, H. S. and Strong, J. M.: Eŝect of albumin on the estimation, in vitro, of phenytoin Vmax and Km values: Implications for clinical correlation. J. Pharmacol. Exp. Ther., 282: 391-396 (1997).
18. Carlile, D. J., Hakooz, N., Bayliss, M. K. and Houston, J. B.: Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans. Br. J. Clin. Pharmacol., 47: 625-635 (1999).
19. Qiu, W., Kunze, K. L., Mather, G. G., Black, C. and Levy, R. H.: Phenytoin and tolbutamide metabolism in human liver microsomes: Complex eŝects of albumin on P450 activity. Drug Metab. Rev., 32: supp. 2, 222 (2000).
20. Li, A. P., Sakai, Y., Lu, C., Fackett, A. and Lin, J.: Protein binding and drug metabolism: Eŝects of human serum albumin on coumarin metabolism in human hepatocytes. Drug Metab. Rev., 32: supp. 2, 242 (2000).
21. Ishii, M., Xu, B. Q., Ding, L. R., Fischer, N. E. and Inaba, T.: Interaction of plasma proteins with cytochromes P450 mediated metabolic reactions: inhibition by human serum albumin and alpha-globulins of the debrisoquine 4-hydroxylation (CYP2D) in liver microsomes of human, hamster and rat. Toxicol. Lett., 119: 219-225 (2001).
22. Obach, R. S.: Nonspecîc binding to microsomes: Impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. Drug Metab. Dispos., 25: 1359-1369 (1997).
23. Obach, R. S.: Prediction of human clearance of twentynine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecîc binding to microsomes. Drug Metab. Dispos., 27: 1350-1359 (1999).
24. Knodell, R. G., Hall, S. D., Wilkinson, G. R. and Guengerich, F. P.: Hepatic metabolism of tolbutamide: Characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. J. Pharmacol. Exp. Ther., 241: 1112-1119 (1987).
25. Yamazaki, H., Inoue, K., Chiba, K., Ozawa, N., Kawai, T., Suzuki, Y., Goldstein, J. A., Guengerich, F. P. and Shimada, T.: Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flubiprofen, and diclofenac by human liver microsomes. Biochem. Pharmacol., 56: 243-251 (1998).
26. Yun, C.-H., Okerholm, R. A., and Guengerich, F. P.: Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metab. Dispos., 21: 403-409 (1993).
27. Boyer, T. D.: The glutathione S-transferases: An update. Hepatology, 9: 486-496 (1989).
28. Ingelman-Sundberg, M., Hagbjork, A. L., Ueng, Y. F., Yamazaki, H. and Guengerich, F. P.: High rates of substrate hydroxylation by human cytochrome P450 3A4 in reconstituted membranous vesicles: influence of membrane charge. Biochem. Biophys. Res. Commun., 221: 318-322 (1996).
29. Yamazaki, H., Johnson, W. W., Ueng, Y. F., Shimada, T. and Guengerich, F. P.: Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4: Characterization of a reconstituted cytochrome P450 3A4WNADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5. J. Biol. Chem., 271: 27438-27444 (1996).
30. Talbert, A.M., Tranter, G. E., Holmes, E. and Francis, P. L.: Determination of drug-plasma protein binding kinetics and equilibria by choromatographic prôling: exemplîcation of the method using L-tryptophan and albumin. Anal. Chem., 74: 445-452 (2002).